)
)
Genetic Analysis Investor Relations Material
Latest events
Status Update
Genetic Analysis
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Genetic Analysis
Access all reports
Segment Data
Access more data
Revenue by
Geography
U.S.
Europe
RoW
Expenses by
Financials
Genetic Analysis AS's mission is to develop, document, clinically validate and commercialize in vitro diagnostic tests for diagnosis and characterizing of dysbiosis in Irritable Bowel Syndrome and Inflammatory Bowel Disease patients. Genetic Analysis AS will initially focus on new ways to help diagnose IBS-D. The company has developed a non-invasive laboratory test for microbiology that can help to confirm the presence of diarrheal IBS. The intent is to provide improved disease characterization for physicians treating large numbers of dysbiosis patients with IBS or IBD with the goal of helping the physician in the management of these patients.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
GEAN
Country
🇳🇴 Norway